• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBiotech

Biotech

Page 18 of 19
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
Tech
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
By Laura LorenzettiJune 30, 2015
This startup wants to farm microbes to create household products
Tech
This startup wants to farm microbes to create household products
By Leena RaoJune 16, 2015
Harvard Interest Rate Swaps
Leadership
Harvard just got its biggest donation ever
By Laura LorenzettiJune 3, 2015
Biopharma deals are booming this year with no end in sight
Finance
Biopharma deals are booming this year with no end in sight
By Laura LorenzettiMay 8, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Finance
Gilead CEO: “We are taking suggestions” on companies to buy
By Jen WiecznerApril 30, 2015
Benchling wants to become the Salesforce of biotech
Tech
Benchling wants to become the Salesforce of biotech
By Laura LorenzettiApril 15, 2015
pancreatic cancer cell
Tech
An audacious attempt to cure pancreatic cancer
By Cyrus SanatiApril 7, 2015
Biotech “bubble” popped, time to buy again?
Finance
Biotech “bubble” popped, time to buy again?
By Jen WiecznerMarch 27, 2015
Biotech pros’ top 8 stock picks
Tech
Biotech pros’ top 8 stock picks
By Jen WiecznerMarch 9, 2015
Logo of Swiss drugmaker Novartis is seen at its headquarters in Basel
Features
FDA approves the first biosimilar for the U.S. market
By Laura LorenzettiMarch 6, 2015
Inside of a Gilead Sciences Lab
Tech
Is the future of pharma about making good drugs great?
By Laura LorenzettiFebruary 27, 2015
Bristol Myers
Finance
Flexus goes from zero to $1.25 billion in 17 months
By Dan PrimackFebruary 24, 2015
Third Rock Ventures: Giving birth to a new generation of biotechs
Tech
Third Rock Ventures: Giving birth to a new generation of biotechs
By Jennifer AlseverFebruary 19, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Finance
After Allergan loss, is Valeant dumpster diving?
By Jen WiecznerJanuary 31, 2015
A powerful new super antibiotic may be right under our feet
Tech
A powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
1...
  • 15
  • 16
  • 17
  • 18
  • 19
19
Most Popular
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billionplaceholder alt text
By Sydney LakeJuly 20, 2026
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimisticplaceholder alt text
By Jason MaJuly 18, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.